NORTH AMERICA COUGH SYRUP MARKET 2023-2030

Triton Market Research’s report states that the cough syrup market in North America is predicted to propel with a CAGR of 2.91% during the forecast years 2023-2030.

Report scope can be customized per your requirements - Request Free Sample Report

The countries explored in the region are:

• United States

• Canada

In North America, the autumn and winter seasons often bring about a prevalence of coughs and colds. During this period, there is an increased demand for cough syrup, driven by individuals seeking relief from common symptoms like coughing, congestion, and sore throat. Many environment residents opt for self-treatment when it comes to minor ailments such as coughs and colds. Over-the-counter (OTC) cough syrups provide a convenient and readily accessible means of managing these symptoms, eliminating the necessity for a doctor’s prescription.

The United States secures a major share of the cough syrup market. The increasing elderly population in the United States is a key factor driving the demand for cough syrups. With advancements in healthcare and longer life expectancy, the elderly demographic in the country continues to expand, leading to a higher prevalence of age-related health issues.

Furthermore, geriatric individuals often have weakened immune systems and chronic medical conditions, making them more prone to respiratory illnesses like colds, bronchitis, and pneumonia. These respiratory conditions frequently result in persistent coughing, which can be particularly distressing. According to the US Census Bureau, as of 2020, the older population comprised 55.8 million people. This rise in the elderly population creates opportunities for the cough syrup market across the US.

Although less prevalent than retail pharmacies, hospital pharmacies hold a vital position in the distribution of cough syrups across diverse healthcare environments. They assume a vital responsibility in overseeing the medication requirements of inpatients, guaranteeing the provision of essential medications, such as cough syrups, as integral components of their treatment regimens. This direct dispensation within the hospital milieu guarantees patients immediate access to the precise medications. The market is sectioned into distribution channel, product type, and age group. The distribution channel is branched into hospital, retail, and e-pharmacies.

The renowned companies in the market include Kenvue Inc, AstraZeneca Plc, Acella Pharmaceuticals LLC, The Himalaya Wellness Company, Merck KGaA, Abbott Laboratories, Glenmark Pharmaceuticals Limited, and Dabur India Ltd.

Kenvue Inc, a United States-based consumer health company, emerged as a distinct entity after being part of Johnson & Johnson’s Consumer Healthcare division. It is headquartered in Montgomery Township, New Jersey. Kenvue boasts a portfolio of renowned brands, including Aveeno, Listerine, Mylanta, Neutrogena, Tylenol, Johnson’s Baby, and Visine. The company’s operations span across the regions of North America, Middle East & Africa, Asia-Pacific, and Latin America.

Key deliverables of the report:

· Market CAGR during the forecasting years 2023-2030

· Detailed data highlighting key insights, industry components, and market strategies

· Comprehensive information and estimation of the cough syrup market revenue growth in North America and its influence on the parent market

· In-depth study of forthcoming trends in consumer behavioral patterns

· A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces

· A wide-ranging study of factors that will challenge the NA cough syrup market’s growth during the upcoming years

Want to get specific insights? Our team of analysts can customize this report based on your preferences. Connect with us here.

Major Players in the Market

Related Reports

Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT

Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT

Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT

Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT

Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT

Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Lifesciences

ASIA-PACIFIC ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET 2022-2028

Market by Therapeutics, Diagno ..

VIEW REPORT

Lifesciences

ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET 2022-2028

Market by Type, Application, E ..

VIEW REPORT

Table of Content

1. NORTH AMERICA COUGH SYRUP MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT ANALYSIS ON THE COUGH SYRUP MARKET

2.1.1. COVID-19 IMPACT

2.1.2. UKRAINE-RUSSIA WAR IMPACT

2.2. PORTER’S FIVE FORCES ANALYSIS

2.2.1. THREAT OF NEW ENTRANTS

2.2.2. THREAT OF SUBSTITUTES

2.2.3. BARGAINING POWER OF BUYERS

2.2.4. BARGAINING POWER OF SUPPLIERS

2.2.5. THREAT OF COMPETITIVE RIVALRY

2.3. INDUSTRY COMPONENTS

2.3.1. RAW MATERIALS

2.3.2. MANUFACTURERS

2.3.3. DISTRIBUTORS

2.3.4. RETAILERS

2.4. REGULATORY FRAMEWORK

2.5. KEY MARKET STRATEGIES

2.5.1. COLLABORATIONS

2.5.2. PRODUCT LAUNCHES

2.5.3. ACQUISITIONS

2.5.4. BUSINESS DIVESTITURES & EXPANSIONS

2.6. MARKET DRIVERS

2.6.1. HIGH INCIDENCE OF RESPIRATORY AILMENTS

2.6.2. VULNERABILITY TO RESPIRATORY DISEASES AMONG THE GERIATRIC POPULATION

2.6.3. INNOVATIONS IN COUGH SYRUPS

2.7. MARKET CHALLENGES

2.7.1. OVERDOSE RISKS ASSOCIATED WITH COUGH SYRUPS

2.7.2. STRICT REGULATORY REQUIREMENTS

2.7.3. INCREASING COUGH SYRUP DEATHS DUE TO TOXIC INGREDIENTS

2.8. MARKET OPPORTUNITIES

2.8.1. SELF-MEDICATION TRENDS INCREASE DEMAND FOR OTC DRUGS

2.8.2. HERBAL COUGH SYRUPS EMERGE AS A SAFER ALTERNATIVE

2.8.3. EASE OF PURCHASE OFFERED BY E-COMMERCE CHANNELS

2.8.4. AVAILABILITY OF SUGAR-FREE COUGH SYRUPS

2.8.5. GROWING PREFERENCE FOR HOMEOPATHIC COUGH SYRUPS

2.9. ANALYST PERSPECTIVE

3. NORTH AMERICA COUGH SYRUP MARKET – BY PRODUCT TYPE

3.1. COUGH SUPPRESSANTS

3.2. COMBINATION MEDICINES

3.3. EXPECTORANTS

4. NORTH AMERICA COUGH SYRUP MARKET – BY AGE GROUP

4.1. ADULTS

4.2. ADOLESCENTS

4.3. PEDIATRIC

5. NORTH AMERICA COUGH SYRUP MARKET – BY DISTRIBUTION CHANNEL

5.1. RETAIL PHARMACIES

5.2. HOSPITAL PHARMACIES

5.3. E-PHARMACIES

6. NORTH AMERICA COUGH SYRUP MARKET – BY COUNTRY OUTLOOK

6.1. UNITED STATES

6.1.1. UNITED STATES COUGH SYRUP MARKET FORECAST & PROSPECTS

6.2. CANADA

6.2.1. CANADA COUGH SYRUP MARKET FORECAST & PROSPECTS

7. COMPETITIVE LANDSCAPE

7.1. GSK PLC

7.1.1. OVERVIEW

7.1.2. PRODUCT PORTFOLIO

7.1.3. KEY STRENGTHS

7.1.4. KEY CHALLENGES

7.2. PFIZER INC

7.2.1. OVERVIEW

7.2.2. PRODUCT PORTFOLIO

7.2.3. KEY STRENGTHS

7.2.4. KEY CHALLENGES

7.3. NOVARTIS AG

7.3.1. OVERVIEW

7.3.2. PRODUCT PORTFOLIO

7.3.3. KEY STRENGTHS

7.3.4. KEY CHALLENGES

7.4. RECKITT BENCKISER GROUP PLC

7.4.1. OVERVIEW

7.4.2. PRODUCT PORTFOLIO

7.4.3. KEY STRENGTHS

7.4.4. KEY CHALLENGES

7.5. THE PROCTER & GAMBLE COMPANY

7.5.1. OVERVIEW

7.5.2. PRODUCT PORTFOLIO

7.5.3. KEY STRENGTHS

7.5.4. KEY CHALLENGES

7.6. SANOFI SA

7.6.1. OVERVIEW

7.6.2. PRODUCT PORTFOLIO

7.6.3. KEY STRENGTHS

7.6.4. KEY CHALLENGES

7.7. CIPLA LIMITED

7.7.1. OVERVIEW

7.7.2. PRODUCT PORTFOLIO

7.7.3. KEY STRENGTHS

7.7.4. KEY CHALLENGES

7.8. KENVUE INC

7.8.1. OVERVIEW

7.8.2. PRODUCT PORTFOLIO

7.8.3. KEY STRENGTHS

7.8.4. KEY CHALLENGES

7.9. ASTRAZENECA PLC

7.9.1. OVERVIEW

7.9.2. PRODUCT PORTFOLIO

7.9.3. KEY STRENGTHS

7.9.4. KEY CHALLENGES

7.10. ACELLA PHARMACEUTICALS LLC

7.10.1. OVERVIEW

7.10.2. PRODUCT PORTFOLIO

7.10.3. KEY STRENGTHS

7.10.4. KEY CHALLENGES

7.11. THE HIMALAYA WELLNESS COMPANY

7.11.1. OVERVIEW

7.11.2. PRODUCT PORTFOLIO

7.11.3. KEY STRENGTHS

7.11.4. KEY CHALLENGES

7.12. MERCK KGAA

7.12.1. OVERVIEW

7.12.2. PRODUCT PORTFOLIO

7.12.3. KEY STRENGTHS

7.12.4. KEY CHALLENGES

7.13. ABBOTT LABORATORIES

7.13.1. OVERVIEW

7.13.2. PRODUCT PORTFOLIO

7.13.3. KEY STRENGTHS

7.13.4. KEY CHALLENGES

7.14. GLENMARK PHARMACEUTICALS LIMITED

7.14.1. OVERVIEW

7.14.2. PRODUCT PORTFOLIO

7.14.3. KEY STRENGTHS

7.14.4. KEY CHALLENGES

7.15. DABUR INDIA LTD

7.15.1. OVERVIEW

7.15.2. PRODUCT PORTFOLIO

7.15.3. KEY STRENGTHS

7.15.4. KEY CHALLENGES

8. RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: NORTH AMERICA COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

TABLE 2: REGULATORY FRAMEWORK

TABLE 3: LIST OF COLLABORATIONS

TABLE 4: LIST OF PRODUCT LAUNCHES

TABLE 5: LIST OF ACQUISITIONS

TABLE 6: LIST OF BUSINESS DIVESTITURES & EXPANSIONS

TABLE 7: NORTH AMERICA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2023-2030 (IN $ MILLION)

TABLE 8: NORTH AMERICA COUGH SYRUP MARKET, BY AGE GROUP, 2023-2030 (IN $ MILLION)

TABLE 9: NORTH AMERICA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (IN $ MILLION)

TABLE 10: NORTH AMERICA COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

List of Figures

FIGURE 1: INDUSTRY COMPONENTS

FIGURE 2: NORTH AMERICA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2022 & 2030 (IN %)

FIGURE 3: NORTH AMERICA COUGH SYRUP MARKET, BY COUGH SUPPRESSANTS, 2023-2030 (IN $ MILLION)

FIGURE 4: NORTH AMERICA COUGH SYRUP MARKET, BY COMBINATION MEDICINES, 2023-2030 (IN $ MILLION)

FIGURE 5: NORTH AMERICA COUGH SYRUP MARKET, BY AGE GROUP, 2022 & 2030 (IN %)

FIGURE 6: NORTH AMERICA COUGH SYRUP MARKET, BY ADULTS, 2023-2030 (IN $ MILLION)

FIGURE 7: NORTH AMERICA COUGH SYRUP MARKET, BY ADOLESCENTS, 2023-2030 (IN $ MILLION)

FIGURE 8: NORTH AMERICA COUGH SYRUP MARKET, BY PEDIATRIC, 2023-2030 (IN $ MILLION)

FIGURE 9: NORTH AMERICA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2022 & 2030 (IN %)

FIGURE 10: NORTH AMERICA COUGH SYRUP MARKET, BY RETAIL PHARMACIES, 2023-2030 (IN $ MILLION)

FIGURE 11: NORTH AMERICA COUGH SYRUP MARKET, BY HOSPITAL PHARMACIES, 2023-2030 (IN $ MILLION)

FIGURE 12: NORTH AMERICA COUGH SYRUP MARKET, BY E-PHARMACIES, 2023-2030 (IN $ MILLION)

FIGURE 13: NORTH AMERICA COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2022 & 2030 (IN %)

FIGURE 14: UNITED STATES COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)

FIGURE 15: CANADA COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)